[Federal Register Volume 86, Number 29 (Tuesday, February 16, 2021)]
[Notices]
[Pages 9537-9538]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02978]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-787]


Importer of Controlled Substances Application: Sigma Aldrich Co., 
LLC.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Sigma Aldrich Co. LLC. has applied to be registered as an 
importer

[[Page 9538]]

of basic class(es) of controlled substance(s). Refer to Supplementary 
Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before March 18, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before March 18, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on January 15, 2021, Sigma Aldrich Co., LLC, 3500 Dekalb 
Street, Saint Louis, Missouri 63118-4103, applied to be registered as 
an importer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Cathinone..........................            1235  I
Methcathinone......................            1237  I
Mephedrone (4-Methyl-N-                        1248  I
 methylcathinone).
Gamma Hydroxybutyric Acid..........            2010  I
Tetrahydrocannabinols..............            7370  I
4-Bromo-2,5-dimethoxyamphetamine...            7391  I
4-Bromo-2,5-dimethoxyphenethylamine            7392  I
2,5-Dimethoxyamphetamine...........            7396  I
3,4-Methylenedioxyamphetamine......            7400  I
3,4-Methylenedioxy-N-                          7404  I
 ethylamphetamine.
3,4-Methylenedioxymethamphetamine..            7405  I
4-Methoxyamphetamine...............            7411  I
Dimethyltryptamine.................            7435  I
N-Benzylpiperazine.................            7493  I
Heroin.............................            9200  I
Normorphine........................            9313  I
Amobarbital........................            2125  II
Secobarbital.......................            2315  II
Nabilone...........................            7379  II
Phencyclidine......................            7471  II
Ecgonine...........................            9180  II
Ethylmorphine......................            9190  II
Levorphanol........................            9220  II
Meperidine.........................            9230  II
Thebaine...........................            9333  II
Opium, powdered....................            9639  II
Levo-alphacetylmethadol............            9648  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
sale to research facilities for drug testing and analysis. In reference 
to drug code 7370 (Tetrahydrocannabinols) the company plans to import 
synthetic Tetrahydrocannabinols. No other activity for this drug code 
is authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-02978 Filed 2-12-21; 8:45 am]
BILLING CODE P